NCT05322707View on ClinicalTrials.gov

BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient

PHASE3CompletedINTERVENTIONAL
Enrollment

1,485

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

August 15, 2023

Study Completion Date

August 29, 2023

Conditions
Asthma
Interventions
DRUG

Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg

Inhalation aerosol, 2 actuations orally inhaled twice daily

DRUG

Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol

Inhalation aerosol, 2 actuations orally inhaled twice daily

DRUG

Placebo

Inhalation aerosol, 2 actuations orally inhaled twice daily

Trial Locations (1)

97504

Velocity Clinical Research, Medford

All Listed Sponsors
lead

Cipla Ltd.

INDUSTRY